AKT1 and breast carcinoma: Here, that CPT indicated significant inhibition on both phosphorylated sites, S473 and T308 of AKT in MCF‐7 breast cancer cells, is not related to interference of PTEN, PI3K(p85) and PI3K(p110), but due to dephosphorylation of IRS1.